Hypertension: all 6,834 studies

Page 20 of 69. Open to participants first (972), then studies with results posted, then the rest; newest registration first within each.

• Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe HypertensionCompletedNCT00860262Phase 3Results posted
• Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in HypertensionCompletedNCT00858702Phase 4Results posted
• A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.CompletedNCT00855465Phase 3Results posted
• Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 HypertensionCompletedNCT00853957Phase 4Results posted
• A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial HypertensionTerminatedNCT00853112Phase 2Results posted
• Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic RateTerminatedNCT00849810Not applicableResults posted
• Efficacy Study of Travoprost APS Versus TRAVATANCompletedNCT00848536Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00847626Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00846365Phase 3Results posted
• Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe HypertensionCompletedNCT00841672Phase 3Results posted
• Safety and Efficacy Trial to Treat Diastolic Heart Failure Using AmbrisentanTerminatedNCT00840463Phase 4Results posted
• A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of AgeCompletedNCT00834041Phase 1/2Results posted
• Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the ArteriesCompletedNCT00829296Phase 2/3Results posted
• Mechanisms and Treatment of Intradialytic HypertensionCompletedNCT00827775Phase 4Results posted
• Insulin Resistance in Pulmonary Arterial HypertensionTerminatedNCT00825266Phase 2Results posted
• A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 DrugsCompletedNCT00823043Results posted
• Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During ExerciseCompletedNCT00819767Phase 2Results posted
• Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00818883Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant HypertensionCompletedNCT00817635Phase 2Results posted
• A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With HypertensionCompletedNCT00817414Phase 2Results posted
• An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension SubjectsCompletedNCT00811564Phase 4Results posted
• A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial HypertensionTerminatedNCT00811018Phase 3Results posted
• A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT00810693Phase 3Results posted
• 8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 HypertensionCompletedNCT00809926Phase 4Results posted
• Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle GlaucomaCompletedNCT00809848Phase 1/2Results posted
• Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)TerminatedNCT00806585Phase 2Results posted
• Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00804648Phase 4Results posted
• Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)CompletedNCT00803634Phase 3Results posted
• Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial DysfunctionTerminatedNCT00802893Phase 2Results posted
• Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)CompletedNCT00799604Phase 2Results posted
• Examination of Ocular Surface Effects With Administration of Travatan Z and XALATANCompletedNCT00798759Phase 4Results posted
• Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for HypertensionCompletedNCT00797862Phase 3Results posted
• Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic HypertensionCompletedNCT00797316Phase 4Results posted
• Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding SildenafilTerminatedNCT00796666Phase 3Results posted
• Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term SafetyTerminatedNCT00796510Phase 3Results posted
• Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)TerminatedNCT00795639Phase 3Results posted
• An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) PatientsCompletedNCT00792571Phase 2Results posted
• A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood PressureCompletedNCT00791258Phase 4Results posted
• A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)CompletedNCT00789321Phase 1Results posted
• Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes MellitusCompletedNCT00787605Phase 4Results posted
• A Study on the Long-term Efficacy of Nebivolol After Withdrawal of TherapyCompletedNCT00785512Phase 4Results posted
• Home Blood Pressure Telemonitoring and Case Management to Control HypertensionCompletedNCT00781365Not applicableResults posted
• Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine AloneCompletedNCT00778921Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren AloneCompletedNCT00777946Phase 3Results posted
• Study of Ambrisentan in Participants With Pulmonary HypertensionCompletedNCT00777920Phase 3Results posted
• Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 HypertensionCompletedNCT00772577Phase 4Results posted
• A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive PatientsCompletedNCT00770861Phase 4Results posted
• Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD StudyCompletedNCT00768560Phase 2Results posted
• Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate HypertensionCompletedNCT00765947Phase 4Results posted
• Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe HypertensionCompletedNCT00765674Phase 3Results posted
• Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular HypertensionCompletedNCT00763061Phase 4Results posted
• Phase III Clinical Trial of TRAVATAN Z in Ocular Surface HealthCompletedNCT00761319Phase 3Results posted
• Trial of Low and High Intensity Strategies to Maintain BP ControlCompletedNCT00760552Not applicableResults posted
• Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older PopulationCompletedNCT00760266Phase 4Results posted
• Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential HypertensionCompletedNCT00760214Phase 3Results posted
• The Role of Endothelin in Pulmonary HypertensionCompletedNCT00759408Phase 2Results posted
• A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential HypertensionCompletedNCT00758524Phase 2Results posted
• Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)CompletedNCT00756938Phase 3Results posted
• Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT00749775Results posted
• Intra-Abdominal Hypertension in Neonatal Intensive Care PatientsCompletedNCT00747552Results posted
• Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive PatientsCompletedNCT00744237Phase 4Results posted
• Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) SubjectsCompletedNCT00741819Phase 4Results posted
• The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow DistributionCompletedNCT00741156Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential HypertensionCompletedNCT00739973Phase 3Results posted
• SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)CompletedNCT00739674Phase 3Results posted
• Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African AmericansCompletedNCT00739596Phase 4Results posted
• Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 DiabetesCompletedNCT00738023Phase 4Results posted
• Efficacy and Safety of Cobiprostone in Patients With Portal HypertensionTerminatedNCT00737594Phase 2Results posted
• Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension SubjectsCompletedNCT00735449Phase 4Results posted
• Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive PatientsCompletedNCT00734630Phase 4Results posted
• Iloprost Power Disc-15 in Pulmonary Arterial HypertensionTerminatedNCT00723554Phase 3Results posted
• FFA Hypertension and Inflammation in Lean and Obese SubjectsCompletedNCT00721617Not applicableResults posted
• Iloprost Power 15 in Pulmonary Arterial HypertensionCompletedNCT00709956Phase 3Results posted
• Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial HypertensionCompletedNCT00709098Phase 3Results posted
• Effects of Travatan Z and Xalatan on Ocular Surface HealthCompletedNCT00708422Phase 4Results posted
• Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled StudyCompletedNCT00706134Phase 3Results posted
• Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II HypertensionCompletedNCT00705575Phase 3Results posted
• Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial HypertensionCompletedNCT00705133Phase 2Results posted
• Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisTerminatedNCT00703339Phase 2Results posted
• Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate HypertensionTerminatedNCT00702221Phase 2Results posted
• Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a DayCompletedNCT00700271Phase 4Results posted
• Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential HypertensionCompletedNCT00699192Phase 3Results posted
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.CompletedNCT00698646Phase 4Results posted
• An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.CompletedNCT00696436Phase 3Results posted
• A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00696384Phase 3Results posted
• Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00696241Phase 3Results posted
• One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00695955Phase 3Results posted
• Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00690794Phase 3Results posted
• Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)CompletedNCT00690612Phase 3Results posted
• Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive PatientsCompletedNCT00689819Not applicableResults posted
• Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mgCompletedNCT00687973Phase 4Results posted
• Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled HypertensionCompletedNCT00686803Phase 2Results posted
• The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting GlucoseCompletedNCT00673790Phase 4Results posted
• The Effect of Nebivolol in Hypertensive Patients With Coronary Artery DiseaseCompletedNCT00673075Phase 4Results posted
• Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood PressureCompletedNCT00669279Phase 4Results posted
• Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial HypertensionCompletedNCT00667823Phase 3Results posted
• A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential HypertensionCompletedNCT00667719Phase 3Results posted
• Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic SyndromeCompletedNCT00666848Phase 4Results posted
• The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) MonotherapyCompletedNCT00666536Phase 4Results posted
• Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)CompletedNCT00666328Phase 3Results posted

← Hypertension overview